BPC-157 results: what to expect and when

An experimental repair peptide with mostly animal evidence and a few small human reports.

Also called: BPC 157, BPC157, Body protection compound 157, Bepecin, PL-14736, PCO-02.

Healing and repair peptides · Experimental synthetic pentadecapeptide.

A two-person IV safety pilot used two dosing days, with checks on day three; this did not test a healing course.

Six distinct clinical reports have results, including two abstract-only enema trials. Four registry records have no posted results; long-term benefit and safety remain unknown.

Key studies

  • Enema safety: 32 volunteers: Short enema exposure gave limited tolerability data; it does not establish an oral or injected dose. (source)
  • Ulcerative colitis: 80 mg enema: The only reported controlled efficacy study did not establish a benefit over placebo. (source)
  • Knee pain: joint injections: Patients reported less pain; tissue healing and superiority to rehabilitation remain unproven. (source)
  • Bladder pain: 12 women: A small uncontrolled report found less bladder pain after a single local procedure. (source)
  • IV safety: two adults: Two brief IV exposures cannot establish routine or long-term safety. (source)
  • Dental nerve injury: three cases: A September 2026 case series adds local human exposure, without proving a BPC-157 benefit. (source)

Related to BPC-157

Sources

Sources checked: 2026-10-18.

Information only, not medical advice. Peptifacts does not sell anything and does not link to sellers.